131 related articles for article (PubMed ID: 3394572)
41. Effect of social isolation on corticosterone secretion elicited by histaminergic stimulation.
Gadek-Michalska A; Borycz J; Bugajski J
Agents Actions; 1994 Jun; 41 Spec No():C77-9. PubMed ID: 7976811
[TBL] [Abstract][Full Text] [Related]
42. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal.
Gonzalvez ML; Milanés MV; Martinez-Piñero MG; Marín MT; Vargas ML
Brain Res; 1994 Jun; 647(2):199-203. PubMed ID: 7922496
[TBL] [Abstract][Full Text] [Related]
43. Effect of intracerebroventricular impromidine on pituitary-adrenocortical response to stress in rats.
Bugajski J; Gadek A
Agents Actions; 1984 Jun; 14(5-6):569-73. PubMed ID: 6236678
[TBL] [Abstract][Full Text] [Related]
44. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
Suh HW; Chung KM; Kim YH; Huh SO; Song DK
Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
[TBL] [Abstract][Full Text] [Related]
45. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat.
Saphier D; Welch JE; Chuluyan HE
Eur J Pharmacol; 1993 May; 236(2):183-91. PubMed ID: 8391456
[TBL] [Abstract][Full Text] [Related]
46. Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice.
Oishi R; Baba M; Nishibori M; Itoh Y; Saeki K
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):159-65. PubMed ID: 2566923
[TBL] [Abstract][Full Text] [Related]
47. Antinociceptive effect of centrally administered cimetidine and dimaprit in the rat.
Netti C; Bossa R; Galatulas I; Sibilia V; Pecile A
Pharmacology; 1984; 28(5):262-7. PubMed ID: 6233621
[TBL] [Abstract][Full Text] [Related]
48. Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men.
Coiro V; Chiodera P; Volpi R; Salati G; Ferrari P; Caiazza A; Rossi G
Biomed Pharmacother; 1984; 38(7):358-60. PubMed ID: 6098319
[TBL] [Abstract][Full Text] [Related]
49. Histaminergic stimulation of prolactin secretion mediated via H1- or H2-receptors: dependence on routes of administration.
Knigge U; Matzen S; Warberg J
Neuroendocrinology; 1986; 44(1):41-8. PubMed ID: 2878384
[TBL] [Abstract][Full Text] [Related]
50. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
Alcaraz C; Vargas ML; Fuente T; Milanés MV
J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
[TBL] [Abstract][Full Text] [Related]
51. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
[TBL] [Abstract][Full Text] [Related]
52. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
53. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
Paquette NC; Young GA
Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
[TBL] [Abstract][Full Text] [Related]
54. Histamine as a central modulator of rat intestinal transit.
Parolaro D; Patrini G; Massi P; Mainardi P; Giagnoni G; Sala M; Gori E
J Pharmacol Exp Ther; 1989 Apr; 249(1):324-8. PubMed ID: 2565394
[TBL] [Abstract][Full Text] [Related]
55. The paradoxical stimulatory effect of morphine on LH secretion is dose-dependent and naloxone-reversible.
Van Vugt DA; Baby N; Stewart M; Reid RL
Neuroendocrinology; 1989 Jul; 50(1):109-16. PubMed ID: 2755561
[TBL] [Abstract][Full Text] [Related]
56. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
57. Role of endogenous opioids and histamine in morphine induced emesis.
Gupta YK; Bhandari P; Chugh A; Seth SD; Dixit KS; Bhargava KP
Indian J Exp Biol; 1989 Jan; 27(1):52-4. PubMed ID: 2606522
[TBL] [Abstract][Full Text] [Related]
58. Peripheral and central opioid activity in the analgesic potency of morphine.
Arrigo-Reina R
Agents Actions; 1990 Apr; 30(1-2):210-2. PubMed ID: 2371923
[TBL] [Abstract][Full Text] [Related]
59. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
[TBL] [Abstract][Full Text] [Related]
60. Central effects of histamine and H1 and H2 receptors agonists and antagonists after intraventricular infusion in fowls.
Nisticò G; Rotiroti D; De Sarro A; Naccari F; Stephenson JD
Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):431-50. PubMed ID: 6104348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
